Navigation Links
BioElectronics Announces Distribution Agreement for Sales In India
Date:7/17/2008

ActiPatch(TM) Product Quickly Approaches World-wide Availability

FREDERICK, Md., July 17 /PRNewswire-FirstCall/ -- BioElectronics Corporation (Pink Sheets: BIEL) announces today a new distribution agreement with Piramal Healthcare Limited has been made for distribution of BioElectronic's revolutionary ActiPatch product.

Piramal Healthcare Limited (earlier Nicholas Piramal India Limited) is one of India's largest companies with strong brand management and sales capabilities. PHL has emerged among the leaders in Indian pharma with one of the widest product portfolios in India.

Andrew J. Whelan, CEO of BioElectronics Corporation, explains, "This is an important and significant order for BioElectronics Corporation. We continue to be excited about developing strong sales in the international marketplace. Piramal Healthcare is an aggressive player and the right partner to help us roll our product out into one of the most populous countries in the world."

Dr. Swati Piramal, Director, Piramal Healthcare Ltd., said, "At Piramal we believe that we should care for the world we share and serve. With the Actipatch launch, we are delighted to bring a breakthrough technology to India to offer a cost effective healing solution." Actipatch(TM), the product marketed by BioElectronics Corp. is changing the face of medicine and the way we heal. Recently chosen as "One of 9 Medical Breakthroughs That May Change Your Life," by Medical Headway.com, ActiPatch is fast becoming the treatment of choice for everything in soft tissue injuries including surgical recovery.

ActiPatch is a drug-free wafer thin patch with an embedded battery-operated microchip that delivers weeks of continuous pulsed RF therapy for less than a dollar a day. The unique ActiPatch delivery system, using patented technology, provides a cost-effective, home use method that reduces soft tissue pain and swelling, and accelerates healing.

Piramal Healthcare will distribute ActiPatch in the Indian market both on medical and retail levels in August 2008.

For more information visit http://www.bioelectronicscorp.com or call 866-757-2284.

Information on ActiPatch and BioElectronics Corporation is available at the following websites:
-- U.S. Consumer http://www.actipatchonline.com

-- Podiatry: http://www.pemfpodiatry.com

-- Plastic Surgery: http://www.plasticsurgeryrelief.com and http://www.makemeheal.com

-- German orthopedic foot & ankle: http://www.diesfussexperten.de

-- Italy and Switzerland: http://www.actipatch.it

-- Canada: http://www.actipatchpaintherapy.ca

-- Netherlands: http://www.actipatch.de

-- Singapore & Malaysia: http://www.astonixlife.com/

-- BioElectronics Corp: http://www.bioelectronicscorp.com

About Piramal Healthcare Limited

Piramal Healthcare Ltd. is one of India's largest pharmaceutical companies, with a growth track record of above 30% CAGR since 1988. Piramal Healthcare had consolidated revenues of US$ 718 million in FY2008. The Company is currently ranked 4th in the Indian market with a diverse product portfolio spanning nine therapeutic areas. The Company is also one of the largest custom manufacturing companies with a global footprint of assets across North America, Europe and Asia. Piramal Healthcare is listed in India on the National Stock Exchange (Ticker: PIRHEALTH) and the Bombay Stock Exchange (Ticker: 500302).

Safe Harbor Statement

This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the company has no control.

Media Relations Contact:

Patricia Baker, The Big Picture Agency LLC

Voice: 413-623-0950 ext. 221, email: pbaker@bigpictureagency.com

Investor Relations Contact:

Joe Noel, Emerging Growth Research LLP

Voice: 925-922-2560, email: jnoel701@yahoo.com


'/>"/>
SOURCE BioElectronics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even
2. BioElectronics Announces Conference Call to Update Investors on Growth Initiatives
3. BioElectronics Corporation Receives Major Orders From Italian Distributor
4. BioElectronics Launches 1 Day Breast Augmentation Recovery Kit
5. BioElectronics Announces Canadian Retail Product Launch
6. BioElectronics Corporation Announces Distribution Agreement With TSS Medical of Italy
7. BioElectronics Corporation Announces Singapore and Malaysia Sales
8. Advanced Life Sciences Announces Collaboration With UK Ministry of Defence on ALS-886
9. Arno Therapeutics Announces New Ticker Symbol
10. Sangamo BioSciences Announces Second Quarter Conference Call and Webcast
11. Monogram Biosciences Announces Second Quarter 2008 Financial Results Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... on what they believe could be a new and helpful biomarker for malignant ... Click here to read it now. , Biomarkers are components in ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial ... Cary 5000 and the 6000i models are higher end machines that use the more ... the spectrophotometer’s light beam from the bottom of the cuvette holder. , FireflySci ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
Breaking Biology Technology:
(Date:6/20/2016)... June 20, 2016 Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring ... involved, it has secured the final acceptance by ... for Managed Access Systems (MAS) installed. Furthermore, Securus ... to be installed by October, 2016. MAS distinguishes ...
(Date:6/9/2016)... -- Paris Police Prefecture ... to ensure the safety of people and operations in several ... tournament Teleste, an international technology group specialised in ... that its video security solution will be utilised by ... safety across the country. The system roll-out is scheduled for ...
(Date:6/2/2016)... The Weather Company , an IBM Business (NYSE: IBM ... which consumers will be able to interact with IBM Watson ... or text and receive relevant information about the product or ... long sought an advertising solution that can create a one-to-one ... valuable; and can scale across millions of interactions and touchpoints. ...
Breaking Biology News(10 mins):